Age, Biography and Wiki

Mark Kendall was born on 16 April, 1972 in Australian, is a Biomedical engineer.

Popular AsN/A
OccupationBiomedical engineer
Age48 years old
Zodiac SignAries
Born16 April 1972
Birthday16 April

Mark Kendall Height, Weight & Measurements

At 48 years old, Mark Kendall height not available right now. We will update Mark Kendall’s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
HeightNot Available
WeightNot Available
Body MeasurementsNot Available
Eye ColorNot Available
Hair ColorNot Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don’t have much information about He’s past relationship and any previous engaged. According to our Database, He has no children.

ParentsNot Available
WifeNot Available
SiblingNot Available
ChildrenNot Available

Mark Kendall Net Worth

He net worth has been growing significantly in 2018-19. So, how much is Mark Kendall worth at the age of 48 years old? Mark Kendall’s income source is mostly from being a successful . He is from Australian. We have estimated Mark Kendall’s net worth, money, salary, income, and assets.

Net Worth in 2020$1 Million – $5 Million
Salary in 2019Under Review
Net Worth in 2019Pending
Salary in 2019Under Review
HouseNot Available
CarsNot Available
Source of Income

Mark Kendall Social Network

WikipediaMark Kendall Wikipedia



At WearOptimo and the Australian National University (2018 to present), Kendall has invented the Microwearable sensor for personalised medicine.

In 2018, Kendall founded WearOptimo where he serves as CEO and is driving forward his Microwearable sensor technology for precision medicine.


Kendall founded Vaxxas in 2011 to commercialise his Nanopatch technology, securing $40 million of investment in the series A and B rounds. The technology has been licensed to Merck & Co. He served as the Vaxxas Chief Technology Officer, Director, and Chair of the Vaxxas Advisory Board (2011-2015).


At the Univeristy of Queensland (2006-2018) Kendall invented the Nanopatch for improved needle-free delivery.


As Associate Director of the Oxford University PowderJect Research Centre (2000-2006), Kendall advanced biolistics technology, commercialised with PowderJect, purchased by CHiron in 200,3 and then with PowderMed, purchgased by Pfizer in 2006.


At the University of Oxford. (1998-2006) Kendall developed, with others, a biolistic technique for the delivery of vaccines directly into the skin without the use of needles.


Mark A. F. Kendall (BE PhD FRSA FTSE) (born 1972) is an Australian biomedical engineer, inventor, scientist and entrepreneur. He is Founder and CEO of WearOptimo Pty Ltd, and the Vice-Chancellor’s Entrepreneurial Professor at the Australian National University.

Kendall was born on April 16th 1972. He received his Bachelors of Engineering (Hons I, 1993) and PhD (1998) from University of Queensland,